quantifying mutant myd88 expression to track disease burden in wm
Published 9 months ago • 125 plays • Length 1:33Download video MP4
Download video MP3
Similar videos
-
4:02
myd88-mutated igm monoclonal gammopathies: chromatin accessibility and transcription factor dynamics
-
1:25
a single-cell analysis of myd88-mutated and myd88 wild-type waldenström's macroglobulinemia
-
2:20
barriers to the implementation of mrd-guided treatment into cll clinical practice
-
0:58
reducing inequalities in the diagnosis and treatment of hematological malignancies
-
2:13
the potential of fixed-duration btkis and using mrd to guide treatment discontinuation in wm
-
2:11
targeted rna-sequencing for the quantification of mrd in aml
-
2:31
officials say 130 suspected victims of possible energy weapon
-
6:11
first-in-human study of the menin-kmt2a inhibitor jnj-75276617 in r/r acute leukemias
-
21:38
drawing the line: the rationale behind blood tube collection order
-
4:47
a study investigating the incidence of clonal hematopoiesis-related mutations in low-count mbl
-
1:45
mrd in wm: its potential in guiding treatment decisions and as a surrogate endpoint in trials
-
1:33
a study investigating treatment prior to autosct in poems syndrome
-
1:32
factors contributing to the pathogenesis of icaht
-
2:14
guidance on mutational testing for diagnosing and monitoring cml
-
1:38
feasibility study of computer vision for quantifying cardiac amyloid burden in biopsies
-
1:53
the future of multiple myeloma treatment
-
1:06
overview of the diagnostic work-up for hemophilia
-
0:41
isct in bringing together the scientific community
-
5:07
daratumumab in the management of al amyloidosis
-
1:21
mrd sequencing test approved for mm in the us
-
1:38
diagnostic and clinical impact of the revised definition of light chain mgus